Day: January 16, 2023

Harvest volumes Q4 2022 (1)Farming Norway 87.0 thousand tonnesFarming Scotland 10.5 thousand tonnesFarming Chile 18.5 thousand tonnesFarming Canada 11.0 thousand tonnesFarming Ireland 0.5 thousand tonnesFarming Faroes 3.0 thousand tonnesTotal 130.5 thousand tonnes   In connection with the presentation of the Q3 2022 results, Mowi ASA guided a total harvest volume of 127 thousand tonnes (GWE) for Q4 2022. Full year harvest volumes were 464 thousand tonnes. Note:(1) The harvest volumes are provided in gutted weight equivalents (GWE). Additional information Operational EBIT for the Group was approximately EUR 239 million in Q4 2022 (EUR 146 million in Q4 2021). Full year Operational EBIT was approximately EUR 1 005 million in 2022. Total Operational EBIT per kg through the value chain was approximately as follows:Norway EUR  ...

TAIPEI, Taiwan, Jan. 16, 2023 (GLOBE NEWSWIRE) — WTW (NASDAQ: WTW), a leading global advisory, broking and solutions company, today announced the appointment of Tony Yen as Head of Taiwan, effective 1 January 2023. Tony succeeds Charles Wang who retired in December 2022. Tony brings with him over 20 years of risk engineering, risk management and insurance broking experience, and joined WTW in 2015. He also heads WTW’s Corporate Risk & Broking (CRB) business in Taiwan and has helped many Taiwanese companies in developing their business continuity and enterprise risk management programmes. In his new role, Tony will work closely with business leaders across WTW to facilitate service delivery and drive growth in Taiwan. Commenting on the appointment, Simon Weaver, Head of Asia Pacific and Head of Corporate Risk & Broking,...

— China commercial launch in multiple provinces and municipalities expected to begin in Q1 2023, and Clover anticipates a significant and sustained long-term annual booster market for its premium, broadly protective protein-based COVID-19 vaccines in China — — SCB-2019 (CpG 1018/Alum) anticipated to receive emergency use authorization (EUA) in at least one additional country and to complete multiple EUA submissions during H1 2023, with commercial value driven via bilateral supply agreements expected beginning in 2023 — — Expansion of Clover’s mid- to late-stage pipeline expected starting in H1 2023, with a focus on (1) building a leading respiratory vaccine franchise and (2) establishing a presence in the pediatric vaccine market in China and the Asia Pacific — SHANGHAI, China, Jan. 15, 2023 (GLOBE...